selected publications

• letter

  • A multicenter study in mexico finds acinetobacter baumannii clinical isolates belonging to clonal complexes 636B (113B) and 92B harboring OXA-72, OXA-239, and OXA-469.  Antimicrobial Agents and Chemotherapy. 2587-2588. 2016-01-01
  • Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-α inhibitors in selected patients in developing countries?.  Journal of Rheumatology. 672-673. 2010-01-01

• article

  • Green, novel, and one-step synthesis of silver oxide nanoparticles: antimicrobial activity, synergism with antibiotics, and cytotoxic studies.  New Journal of Chemistry.  46:17841-17853. 2022-01-01
  • Serum zinc levels are associated with obesity and low-density lipoprotein cholesterol in Mexican adults.  Journal of Trace Elements in Medicine and Biology.  73:-. 2022-01-01
  • A population approach of rifampicin pharmacogenetics and pharmacokinetics in Mexican patients with tuberculosis.  Tuberculosis.  124:-. 2020-01-01
  • Characterization, antibiofilm and biocompatibility properties of chitosan hydrogels loaded with silver nanoparticles and ampicillin: an alternative protection to central venous catheters.  Colloids and Surfaces B: Biointerfaces.  196:-. 2020-01-01
  • Population pharmacokinetics of amikacin administered once daily in patients with different renal functions.  Antimicrobial Agents and Chemotherapy.  64:-. 2020-01-01
  • Population pharmacokinetics of isoniazid and dose recommendations in Mexican patients with tuberculosis.  International Journal of Clinical Pharmacy.  42:1217-1226. 2020-01-01
  • Prevalence and genotypic characterization of methicillin-resistant strains of staphylococcus aureus isolated in a mexican regional hospital [Prevalencia y caracterización genotípica de cepas de staphylococcus aureus resistente a meticilina aisladas en un hospital regional mexicano].  Revista Chilena de Infectologia.  37:37-44. 2020-01-01
  • Anthropometric and Genetic Factors Associated with the Exposure of Rifampicin and Isoniazid in Mexican Patients with Tuberculosis.  Therapeutic Drug Monitoring.  41:648-656. 2019-01-01
  • Comparison of Rates of Hospitalization between Single and Dual Virus Detection in a Mexican Cohort of Children and Adults with Influenza-Like Illness.  Open Forum Infectious Diseases.  6:-. 2019-01-01
  • Glycerophospholipid Metabolism Alterations in Patients with Type 2 Diabetes Mellitus and Tuberculosis Comorbidity.  Archives of Medical Research.  50:71-78. 2019-01-01
  • Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses.  Influenza and other Respiratory Viruses.  13:3-9. 2019-01-01
  • “Differential risk of hospitalization among single virus infections causing influenza-like illnesses”.  Influenza and other Respiratory Viruses.  13:36-43. 2019-01-01
  • Adhesion forces of biofilms developed in vitro from clinical strains of skin wounds.  Materials Science and Engineering C.  82:336-344. 2018-01-01
  • Analysis of transcription factors, microRNAs and cytokines involved in T lymphocyte differentiation in patients with tuberculosis after directly observed treatment short-course.  Tuberculosis.  105:1-8. 2017-01-01
  • Anti-biofilm activity of chitosan gels formulated with silver nanoparticles and their cytotoxic effect on human fibroblasts.  Materials Science and Engineering C.  60:317-323. 2016-01-01
  • Outbreak Caused by blaOXA-72-Producing Acinetobacter baumannii ST417 Detected in Clinical and Environmental Isolates.  Microbial Drug Resistance.  22:129-133. 2016-01-01
  • Clinical pharmacokinetics of rifampin in patients with tuberculosis and type 2 diabetes mellitus: Association with biochemical and immunological parameters.  Antimicrobial Agents and Chemotherapy.  59:7707-7714. 2015-01-01
  • Diabetes and other risk factors for multi-drug resistant tuberculosis in a mexican population with pulmonary tuberculosis: Case control study.  Archives of Medical Research.  46:142-148. 2015-01-01
  • Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population.  Molecular Biology Reports.  41:7833-7843. 2014-01-01
  • Pharmacokinetics of rifampicin in Mexican patients with tuberculosis and healthy volunteers.  Journal of Pharmacy and Pharmacology.  66:1421-1428. 2014-01-01
  • Relative bioavailability of isoniazid in a fixed-Dose combination product in healthy Mexican subjects.  International Journal of Tuberculosis and Lung Disease.  18:49-54. 2014-01-01
  • Risk factors for severe influenza A virus pneumonia in adult cohort, Mexico, 2013-14.  Emerging Infectious Diseases.  20:1554-1558. 2014-01-01
  • Population pharmacokinetics of rifampicin in Mexican patients with tuberculosis.  Journal of Clinical Pharmacy and Therapeutics.  38:56-61. 2013-01-01
  • Invasive fungal infections in patients with systemic lupus erythematosus.  Journal of Rheumatology.  39:1814-1818. 2012-01-01
  • Renal function assessment in patients with systemic lupus erythematosus.  Rheumatology International.  32:2293-2299. 2012-01-01
  • Relative bioavailability of rifampicin in a three-drug fixed-dose combination formulation.  International Journal of Tuberculosis and Lung Disease.  14:1454-1460. 2010-01-01
  • Severe pneumonia associated with pandemic (H1N1) 2009 outbreak, San Luis Potosí, Mexico.  Emerging Infectious Diseases.  16:27-34. 2010-01-01
• Metabolomics applied to the discovery of tuberculosis and diabetes mellitus biomarkers.  Biomarkers in Medicine. 1001-1013. 2018-01-01